Advertisement

Topics

Latest "At Pappas Ventures" News Stories

17:16 EDT 21st July 2018 | BioPortfolio

Here are the most relevant search results for "At Pappas Ventures" found in our extensive news archives from over 250 global news sources.

More Information about At Pappas Ventures on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about At Pappas Ventures for you to read. Along with our medical data and news we also list At Pappas Ventures Clinical Trials, which are updated daily. BioPortfolio also has a large database of At Pappas Ventures Companies for you to search.

Showing "Pappas Ventures" News Articles 1–25 of 998

Saturday 21st July 2018

Global Polyurethane PU HotMelt Adhesive Market Segmented by Type, Application, and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

In 2017, the global polyurethane hotmelt adhesives market was expected to be valued at USD 1,090.41 million, and it is expected to reach a value of USD 1,712.79 million by 2023. Hotmelt adhesives, also known as hot glue, are solventfree and thermoplastic materials. These adhesives are melted and applied on the surface, which solidify on cooling and are strong adhesives. They are applied in a molte...


China Investors Lead $15.5 Million Round in Quantapore, a US Sequencing Co.

Northern Light Venture Capital, a China investor, led a $15.5 million C Series financing in Quantapore, a Silicon Valley company that is developing a novel nanopore genomic sequencing technology. Breaking out of stealth mode, Quantapore says its optical machines can sequence DNA rapidly and accurately at one-tenth the current cost. Tsingyuan Ventures and Sangel Venture Capital were also major inve...

Friday 20th July 2018

Global Craft Beer Market Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $1923

Beer Industry may have attained a maturation stage particularly in the developed markets, but the flavorful revolution has begun to fetch higher sales worldwide and this innovation is significantly visible in the form of CraftBeer.Craft beer is brewed by a small, independent, and traditional brewer. The global craft beer market accounted for USD 38,183.52 million and it is expected to attain a CAG...


Kronos Bio raises $18mm in seed funding

Cancer drug discovery firm Kronos Bio Inc. raised $18mm in seed funding from Omega Funds, BellCo Capital, Vida Ventures, and ...

Series A round brings €16mm to Lava Therapeutics

Lava Therapeutics BV raised €16mm ($18.9mm) through its Series A round. Gilde Healthcare and Versant Ventures co-led, with ...

StrideBio gets $15.7mm via Series A

StrideBio Inc. (developing novel adeno-associated viral (AAV) vectors for in vivo gene therapies aimed at rare diseases) rais...

Thursday 19th July 2018

Centivo Raises $34M to Launch Next-Gen Self-Funded Health Plan

Centivo, a new type of self-funded health plan built specifically for employers and their employees and families has raised $34 million in Series A funding led by Bain Capital Ventures. The round also included participation from F-Prime Capital Partners, Maverick Ventures, Bessemer Venture Partners, Ingleside Investors, Rand Capital, Grand Central Tech Ventures, Oxeon Investments, and ... Read Mor...

#Cannabisstocks: FSD Pharma (CSE:HUGE) (OTC:FSDDF) Enters Into Saskatchewan Wholesale Supply MOU of Up To 5,000 Kilograms With High Tide Ventures

Toronto - July 19, 2018 (Investorideas.com Newswire) FSD Pharma Inc. ("FSD Pharma") (CSE:HUGE) (OTC:FSDDF) today announced that its wholly-owned subsidiary, FV Pharma Inc. ("FV Pharma") has entered into a non-binding memorandum of understanding ("MOU") with High Tide Ventures Inc. ("High Tide") dated July 18, 2018 to supply the Saskatchewan market on a wholesale basis with up to 5,000 kilograms of...

Wednesday 18th July 2018

Compass Therapeutics closes $132mm Series A round

Compass Therapeutics (antibody therapies for cancer) raised a total of $132mm through a multi-tranche Series A round that beg...

Constellation Pharmaceuticals gets $24.3mm through sale of Series E-1 shares; later adds $24.2mm

Constellation Pharmaceuticals Inc. (epigenetics-based cancer drug discovery) raised $24.3mm through the sale of Series E-1 sh...

Quantapore Inc. Closes Series 3 Financing Round to Fund Beta Launch of DNA Sequencer

Quantapore Inc. announced the completion of a $15.55 million sale of Series 3 Preferred Stock led by Northern Light Venture Capital (NLVC). Tsingyuan Ventures and Sangel Venture Capital were major investors in the round and were joined by Baidu Ventures and Cloudstone VC. Mr. Feng Deng of NLVC has joined Quantapore’s Board of Directors. Quantapo...

Startup World Cup 2019 Applications are Open

Fenox Venture Capital’s global business plan competition, with a $1,000,000 grand prize, is looking for brilliant startups, regional partners, and corporate sponsors Startup World Cup, a global startup pitch competition with a $1,000,000 grand prize, returns for a third year searching for the next world champion amongst the top start...

Tenet Announces Definitive Agreement with Pipeline Health and TWG Partners Regarding the Sale of Tenet’s Three Chicago-Area Hospitals

Tenet Healthcare Corporation (NYSE: THC), Pipeline Health LLC, a national operator of hospitals and other healthcare facilities, and TWG Partners, LLC, a Chicago-based healthcare investment firm founded by Eric E. Whitaker, MD, MPH, have entered into a definitive agreement regarding the sale of Tenet’s remaining acute care hospitals in the Chicago area. ...

Viz.ai Raises $21 M in Series A Funding From Kleiner Perkins and GV to Increase Patient Access to Proven Therapies

Viz.ai, an applied artificial intelligence (AI) healthcare company focused on time sensitive conditions, has secured $21 million in Series A funding led by Kleiner Perkins, with participation from GV, formerly Google Ventures. Founded in 2016 by Dr. Chris Mansi and Dr. David Golan, Viz.ai has built the first FDA cleared computer aided triage software to de...

Catapult appoints Chris Spencer as Venture Partner

Catapult Ventures has announced that Chris Spencer has been appointed as a Venture Partner with its GM&C Life Sciences Fund. Chris Spencer, who becomes the Fund’s fourth Venture Partner, will assess investment opportunities and work with the Fund’s smaller investments to help companies successfully grow, with a particular focus on digital health. Speaking on the new appointment, Ca...

Tuesday 17th July 2018

Kindly Care Lands $5.4M to Expand Elder Care Marketplace

Kindly Care, a San Francisco, CA-based elder care marketplace, today announced it has raised $5.4 million in Series A funding led by Javelin Venture Partners. The round also included participation from MHS Capital and Jackson Square Ventures.  Kindly Care plans to utilize the latest round of funding to fuel additional growth of the company’s vision to provide ... Read More

Pliant closes $62mm Series B round

Pliant Therapeutics Inc. (therapies for fibrotic disorders) raised $62mm in its Series B financing led by Cowen Healthcare In...

K Health Launches Free Primary Care App with Providers in New York

K is the first primary care app powered by true AI and the experience of thousands of doctors and hundreds of millions of physician notes, lab results, treatments and prescriptions K Health today announced the launch of K, a free, first-of-its-kind primary care app along with a new provider network available in New York. K is the first app to us...

CyberMDX Raises $10 Million Series A to Expand Medical Cybersecurity to Hospitals Worldwide

Funding validates company’s market traction and will support its growth and expansion CyberMDX, a leading healthcare cybersecurity provider delivering visibility and threat prevention for medical devices and clinical networks, announced today the completion of a $10 million Series A financing. The round was led by Pitango Venture Capital, with...

Slone Partners, Where People Are Our Science™, Places New Chief Medical Officer, Garrett K. Lam M.D. FACOG, at Sera Prognostics, Inc.

Successful nationwide search secures former professor and Chairman of the Department of Obstetrics & Gynecology at the University of Tennessee College of Medicine-Chattanooga, who will direct all clinical development activities for The Pregnancy Company™ BOSTON (PRWEB) July 17, 2018 Slone Partners, North America’s leading executive search firm for life sciences, diagnostics and scientific...

Monday 16th July 2018

Antiva gets $15mm in Series C-1 financing

Antiva Biosciences Inc. (therapies for diseases caused by human papilloma virus) raised $15mm in its Series C-1 financing led...

Series B brings in $12mm for Cagent Vascular

Cagent Vascular LLC (angioplasty balloons) raised $12mm in its Series B led by two undisclosed strategic investors, which wer...

Octave Bioscience raises $14 million for MS care management system in Series A round

BCBS Venture Partners leads round, with Section 32, Echo Health Ventures and others participating.

Sunday 15th July 2018

Flare Capital Partners, 7wire Ventures lead higi’s $21.3M Series C round

The population health startup will use the funding to foster additional engagement with consumers, expand its access points and advance collaboration with healthcare delivery systems.

Saturday 14th July 2018

2018 Top 5 Solar Grade Multi Crystal Silicon Ingot Players in North America, Europe, AsiaPacific, South America, Middle East and Africa [Report Updated: 06062018] Prices from USD $4960

Solar grade multi crystal silicon ingot is a tablet form of metal products which is produced by pouring the polysilicon into the reused mold. grade multi crystal silicon ingots are necessary for the manufacture of IC's.Solar grade multi crystal silicon ingot industry concentration is relatively low and the manufacturers distributed mainly over Asia and Europe. The solar grade multi crystal silicon...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks